Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Precipio Inc (PRPO)

Precipio Inc (PRPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting GlobeNewswire - Fri Dec 5, 9:00AM CST

NEW HAVEN, Conn., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) will be presenting at ASH the findings of a joint study conducted with...

PRPO : 24.02 (-2.40%)
Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact GlobeNewswire - Thu Dec 4, 7:00AM CST

NEW HAVEN, Conn., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Precipio, Inc. reports that the Company recently identified a single, limited scope unauthorized access to a specific data folder stored within its...

PRPO : 24.02 (-2.40%)
Precipio Announces its Q3-2025 Financial Results GlobeNewswire - Fri Nov 14, 3:30PM CST

NEW HAVEN, Conn., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.   (NASDAQ: PRPO) , filed its 10-Q report today. The following are the highlights of the Company’s...

PRPO : 24.02 (-2.40%)
Precipio Announces Q3-2025 Shareholder Update Call GlobeNewswire - Tue Nov 4, 4:00PM CST

NEW HAVEN, Conn., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q3-2025 corporate update call on November 17 th , 2025...

PRPO : 24.02 (-2.40%)
Precipio Terminates Its ATM GlobeNewswire - Tue Sep 2, 9:00AM CDT

NEW HAVEN, Conn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) , has terminated its ATM (At-The-Market) instrument with investment bank...

PRPO : 24.02 (-2.40%)
Precipio Announces its Q2-2025 Financial Results GlobeNewswire - Wed Aug 13, 4:00PM CDT

NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) , filed its 10-Q report today. The following are the highlights of the...

PRPO : 24.02 (-2.40%)
Precipio Announces Q2-2025 Shareholder Update Call GlobeNewswire - Thu Jul 31, 3:30PM CDT

NEW HAVEN, Conn., July 31, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q2-2025 corporate update call on August 14 th , 2025...

PRPO : 24.02 (-2.40%)
Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless GlobeNewswire - Fri Jul 11, 3:30PM CDT

PRPO : 24.02 (-2.40%)
Medicine labratory by gorodenkoff via iStock
Arena Group Holdings vs. Precipio: 2 New Top 100 Stocks to Buy. Precipio’s the Buy. Barchart - Tue Jul 8, 11:02AM CDT

Arena Group Holdings and Precipio entered Barchart’s Top 100 Stocks to Buy on Monday. Both are up more than 100% in 2025. However, when it comes down to making a bet, the latter is the wiser long-term...

AREN : 4.29 (-3.81%)
PRPO : 24.02 (-2.40%)
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting GlobeNewswire - Mon Jun 16, 11:00AM CDT

PRPO : 24.02 (-2.40%)

Barchart Exclusives

As Nike Shakes Up Its C-Suite, Should You Buy, Sell, or Hold NKE Stock? Barchart - 1 hour ago
Nike’s sweeping C-suite overhaul under its “Win Now” plan signals a bold reset. So, is the stock a buy, sell, or hold? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot